首頁 > 市場調查報告書 > 製藥

基因治療學和RNAi 以基因為基之藥物開發

市場調查報告書

商品編碼

1825294

CRISPR市場 - 預測2025-2030

CRISPR Market - Forecasts from 2025 to 2030

出版日期: 2025年08月23日 | 出版商:

Knowledge Sourcing Intelligence | 英文 147 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

預計 CRISPR 市場規模將從 2025 年的 55.65 億美元成長到 2030 年的 95.51 億美元，複合年成長率為 11.41%。

全球 CRISPR 市場代表著一個快速擴張的生物技術領域，其驅動力來自新興市場的大量投資以及成簇規律間隔短回文重複序列 (CRISPR) 技術的革命性潛力。這種尖端的基因組編輯工具正在改變基因工程、生物技術、製藥和農業等多個行業，並已成為現代分子研究和治療開發的基礎技術。

技術應用與市場基礎設施

CRISPR技術利用分子機器和工程核酸酶實現精準的基因組編輯，從而促進生物DNA的缺失、插入和替換。它支援多種應用，包括基因破壞、同源定向修復以及建構包含功能性遺傳訊息的克隆DNA片段的基因文庫。對於在各個研究領域需要進行精準基因改造的研究人員來說，質體已成為不可或缺的工具。

CRISPR 的多功能性已超越傳統研究領域，拓展至商業性農業開發領域。基因編輯作物正被改造以增強營養成分並改善消費者可接受的性狀。此外，該技術還支持先進的基因轉移系統和病毒載體的應用，從而拓展了治療複雜遺傳疾病的潛力。

市場成長的關鍵驅動力

廣泛的應用領域和產品組合

CRISPR 的廣泛應用正在推動多個領域的市場持續擴張。其基因組編輯能力使研究人員能夠應對複雜的遺傳挑戰，也使生物技術公司能夠開發用於農業、製藥和治療應用的創新解決方案。該技術對各種研究環境的適應性正在推動學術機構、生物技術和製藥公司的持續需求。

遺傳疾病盛行率不斷上升

遺傳疾病的日益普及顯著擴大了 CRISPR 技術的市場需求。儘管遺傳疾病本身罕見，但全球約 80% 的罕見疾病都與遺傳疾病有關，這影響了需要創新治療方法的患者群體。這一人口現狀正在創造對基因編輯技術的持續需求，這些技術可以解決先前無法治癒的遺傳疾病。

針對嚴重的先進基因療法應用正在展示 CRISPR 的治療潛力，生物技術公司正在開發合作方法，透過創新的基因療法來治療肌萎縮側索硬化症和福萊德瑞克運動失調症等罕見疾病。

促進研發

廣泛的研發活動為多個治療領域的市場參與企業提供了重大機會。癌症研究尤其受益於 CRISPR 技術，研究人員已從實驗室應用轉向臨床試驗，利用 CRISPR 編輯的免疫細胞來增強癌症的檢測和治療能力。

CRISPR 技術解決了基因編輯領域長期存在的難題，提供了一種快速、簡單且經濟高效的解決方案，滿足了研究人員在各種應用領域的需求。這種便利性正推動著尋求高效基因修飾工具的研究機構和商業企業對其的廣泛應用。

市場限制與挑戰

意識和教育的局限性

缺乏對CRISPR技術更廣泛應用的認知是一大限制因素，尤其是在亞洲和非洲的新興市場。對該技術在科學研究計畫中的潛在應用的了解有限，限制了其在市場中的滲透率以及在潛在用戶的採用率，而這些用戶可能受益於該技術的基因編輯功能。

監管和道德考慮

對CRISPR基因編輯技術可能被濫用的擔憂，對市場發展構成了持續的挑戰。法律規範和倫理準則不斷發展，以解決安全性和應用界限問題，這帶來了不確定性，可能會影響其採用率和商業化開發時間表。

區域市場動態

由於蓬勃發展的製藥和生物技術產業、技術的廣泛應用以及研發活動的活性化，北美在市場上保持主導地位。該地區受益於完善的醫療基礎設施、不斷成長的醫療支出以及對基因改造生物和人類幹細胞應用的強勁需求。

戰略意義

CRISPR 市場蘊藏著巨大的成長機遇，這得益於該技術的多功能性、日益增多的遺傳疾病以及日益加速的研究活動。為了取得成功，企業必須透過教育計畫來彌補認知差距，同時應對不斷變化的監管環境。市場參與企業必須在創新與負責任的市場開發之間取得平衡，以最大限度地發揮其在不同應用領域和地理市場的成長潛力。

本報告的主要優點

深刻分析：獲得深入的市場洞察，重點關注客戶細分、政府政策和社會經濟因素、消費者偏好、垂直行業和其他細分市場，涵蓋主要地區和新興地區。
競爭格局：了解主要企業所採用的策略策略，並了解正確策略的市場滲透潛力。
市場促進因素和未來趨勢：探索動態因素和關鍵市場趨勢以及它們將如何影響未來的市場發展。
可行的建議：利用洞察力來制定策略決策，在動態環境中開闢新的業務流和收益。
受眾廣泛：對於新興企業、研究機構、顧問、中小企業和大型企業來說，既有利又划算。

它有什麼用途？

產業與市場洞察、商業機會評估、產品需求預測、打入市場策略、地理擴張、資本投資決策、法律規範與影響、新產品開發、競爭影響

分析範圍

歷史資料（2022-2024）和預測資料（2025-2030）
成長機會、挑戰、供應鏈前景、法規結構、客戶行為和趨勢分析
競爭對手定位、策略和市場佔有率分析
按部門和地區（國家）分類的收益成長和預測分析
公司概況（策略、產品、財務資訊、主要趨勢等）

介紹
北美洲
- 美國
- 加拿大
- 墨西哥
南美洲
- 巴西
- 阿根廷
- 其他
歐洲
- 德國
- 法國
- 英國
- 西班牙
- 其他
中東和非洲
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 以色列
- 其他
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 印尼
- 泰國
- 台灣
- 其他

第9章競爭格局及分析

主要企業和策略分析
市佔率分析
企業合併、協議、商業合作
競爭對手儀表板

第10章：公司簡介

Addgene
CRISPR Therapeutics
Editas Medicine
GenScript Biotech Corporation
Horizon Discovery（PerkinElmer）
Integrated DNA Technologies, Inc.
Intellia Therapeutics, Inc.
Thermo Fisher Scientific Inc.
Sigma-Aldrich
Caribou Biosciences, Inc.

第11章附錄

貨幣
先決條件
基準年和預測年時間表
相關人員的主要利益
分析方法
簡稱

簡介目錄

Product Code: KSI061610963

The CRISPR market is expected to grow from USD 5.565 billion in 2025 to USD 9.551 billion in 2030, at a CAGR of 11.41%.

The global CRISPR market represents a rapidly expanding biotechnology sector driven by significant investments from developed nations and the revolutionary potential of Clustered Regularly Interspaced Short Palindromic Repeats technology. This cutting-edge genome editing tool has transformed multiple industries including genetic engineering, biotechnology, pharmaceuticals, and agriculture, establishing itself as a cornerstone technology for modern molecular research and therapeutic development.

Technology Applications and Market Foundation

CRISPR technology enables precise genome editing through molecular machinery and designed nucleases, facilitating deletions, insertions, or substitutions in living organism DNA. The technology supports diverse applications including gene disruption, homologous gene direct repair, and gene library development containing cloned DNA fragments with functional gene information. CRISPR plasmids have become essential tools for researchers requiring precise genetic modifications across multiple research domains.

The versatility of CRISPR applications extends beyond traditional research settings into commercial agricultural development, where gene-edited crops offer enhanced nutritional profiles and improved consumer acceptance characteristics. Additionally, the technology supports advanced gene delivery systems and viral vector applications, expanding therapeutic possibilities for complex genetic conditions.

Primary Market Growth Drivers

Extensive Application Portfolio

CRISPR's broad application spectrum drives sustained market expansion across multiple sectors. Genome editing capabilities enable researchers to address complex genetic challenges while supporting biotechnology companies in developing innovative solutions for agricultural, pharmaceutical, and therapeutic applications. The technology's adaptability across diverse research contexts creates sustained demand from academic institutions, biotechnology companies, and pharmaceutical enterprises.

Rising Genetic Disorder Prevalence

The increasing incidence of genetic disorders significantly expands market demand for CRISPR technologies. Genetic illnesses, while individually rare, constitute approximately 80% of rare disorders globally, affecting substantial patient populations requiring innovative therapeutic approaches. This demographic reality creates sustained demand for gene editing technologies capable of addressing previously untreatable genetic conditions.

Advanced gene therapy applications targeting severe illnesses demonstrate CRISPR's therapeutic potential, with biotechnology companies developing collaborative approaches to address rare diseases including amyotrophic lateral sclerosis and Friedreich's ataxia through innovative gene-based treatments.

Research and Development Acceleration

Extensive research and development activities provide significant opportunities for market participants across multiple therapeutic areas. Cancer research particularly benefits from CRISPR technology, as researchers transition from laboratory applications to clinical testing involving CRISPR-edited immune cells designed to enhance cancer detection and treatment capabilities.

The technology addresses long-standing challenges in gene editing by providing rapid, simple, and cost-effective solutions that meet researcher requirements across diverse applications. This accessibility drives adoption across research institutions and commercial enterprises seeking efficient genetic modification tools.

Market Constraints and Challenges

Awareness and Education Limitations

Insufficient awareness regarding CRISPR technology's extensive applications represents a primary market constraint, particularly in developing regions across Asia and Africa. Limited understanding of the technology's potential applications in research initiatives restricts market penetration and adoption rates among potential users who could benefit from genetic editing capabilities.

Regulatory and Ethical Considerations

Potential misuse concerns regarding CRISPR gene editing technologies present ongoing challenges for market development. Regulatory frameworks and ethical guidelines continue evolving to address safety and application boundaries, creating uncertainty that may impact adoption rates and commercial development timelines.

Geographic Market Dynamics

North America maintains significant market leadership driven by thriving pharmaceutical and biotechnology industries, widespread technology adoption, and increasing research and development activities. The region benefits from established healthcare infrastructure, rising healthcare expenditures, and strong demand for genetically modified organisms and human stem cell applications.

Strategic Implications

The CRISPR market presents substantial growth opportunities driven by technological versatility, increasing genetic disorder prevalence, and accelerating research activities. Success requires addressing awareness gaps through education initiatives while navigating evolving regulatory landscapes. Market participants must balance innovation with responsible development practices to maximize growth potential across diverse application areas and geographic markets.

Key Benefits of this Report:

Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

Historical data from 2022 to 2024 & forecast data from 2025 to 2030
Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
Competitive Positioning, Strategies, and Market Share Analysis
Revenue Growth and Forecast Assessment of segments and regions including countries
Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Global CRISPR Market Segments:

By Type

Class 1
Class 2

By Application

Cell & Gene Therapies
Disease Diagnostics
Drug Development
Others

By End-User

Pharmaceuticals & Biotechnology Company
Academic & Research Institutes
Others

By Geography

North America
USA
Canada
Mexico
South America
Brazil
Argentina
Others
Europe
Germany
France
United Kingdom
Spain
Others
Middle East and Africa
Saudi Arabia
UAE
Israel
Others
Asia Pacific
China
India
Japan
South Korea
Indonesia
Thailand
Taiwan
Others

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation

3. BUSINESS LANDSCAPE

3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter's Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. GLOBAL CRISPR MARKET BY TYPE

5.1. Introduction
5.2. Class 1
5.3. Class 2

6. GLOBAL CRISPR MARKET BY APPLICATION

6.1. Introduction
6.2. Cell & Gene Therapies
6.3. Disease Diagnostics
6.4. Drug Development
6.5. Others

7. GLOBAL CRISPR MARKET BY END-USER

7.1. Introduction
7.2. Pharmaceuticals & Biotechnology Company
7.3. Academic & Research Institutes
7.4. Others

8. GLOBAL CRISPR MARKET BY GEOGRAPHY

8.1. Introduction
8.2. North America
- 8.2.1. USA
- 8.2.2. Canada
- 8.2.3. Mexico
8.3. South America
- 8.3.1. Brazil
- 8.3.2. Argentina
- 8.3.3. Others
8.4. Europe
- 8.4.1. Germany
- 8.4.2. France
- 8.4.3. United Kingdom
- 8.4.4. Spain
- 8.4.5. Others
8.5. Middle East and Africa
- 8.5.1. Saudi Arabia
- 8.5.2. UAE
- 8.5.3. Israel
- 8.5.4. Others
8.6. Asia Pacific
- 8.6.1. China
- 8.6.2. India
- 8.6.3. Japan
- 8.6.4. South Korea
- 8.6.5. Indonesia
- 8.6.6. Thailand
- 8.6.7. Taiwan
- 8.6.8. Others